Mayelana-umdlavuza / ukwelashwa / izidakamizwa / isisu

Izidakamizwa zivunyelwe umdlavuza wesisu (Gastric) Cancer

Leli khasi libala imishanguzo yomdlavuza evunyelwe yiFood and Drug Administration (FDA) yomdlavuza wesisu (esiswini). Uhlu lufaka amagama ajwayelekile nawomkhiqizo. Leli khasi futhi libala izinhlanganisela zezidakamizwa ezivamile ezisetshenziswa kumdlavuza wesisu (esiswini). Izidakamizwa ngazinye ezinhlanganisweni zivunyelwe yi-FDA. Kodwa-ke, inhlanganisela yezidakamizwa uqobo ayivunyelwe, yize isetshenziswa kabanzi.

Amagama ezidakamizwa axhumanisa nezifinyezo ze-Cancer Information Information ze-NCI. Kungaba nezidakamizwa ezisetshenziswa kumdlavuza wesisu (esiswini) ezingabhalisiwe lapha.

KULELI KHASI

• Izidakamizwa zivunyelwe umdlavuza wesisu (Gastric) Cancer

• Inhlanganisela Yezidakamizwa Esetshenziswa Emdlavuzeni Wesisu (Gastric) Cancer

• Izidakamizwa zivunyelwe i-Gastroenteropancreatic Neuroendocrine Tumors

Izidakamizwa zivunyelwe umdlavuza wesisu (Gastric) Cancer

ICyramza (iRamucirumab)

I-Docetaxel

I-Doxorubicin Hydrochloride

I-5-FU (Inaliti ye-Fluorouracil)

Inaliti ye-Fluorouracil

I-Herceptin (Trastuzumab)

I-Keytruda (Pembrolizumab)

I-Lonsurf (Trifluridine ne-Tipiracil Hydrochloride)

UMitomycin C.

I-Pembrolizumab

URamucirumab

I-Taxotere (Docetaxel)

I-Trastuzumab

I-Trifluridine ne-Tipiracil Hydrochloride

Inhlanganisela Yezidakamizwa Esetshenziswa Emdlavuzeni Wesisu (Gastric) Cancer

I-FU-LV

TPF

XELIRI

Izidakamizwa zivunyelwe i-Gastroenteropancreatic Neuroendocrine Tumors

I-Afinitor (Everolimus)

I-Afinitor Disperz (Everolimus)

Everolimus

I-Lanreotide Acetate

ISomatuline Depot (iLanreotide Acetate)